Pharnext strengthens its Senior Leadership Team with the appointment of Scott Johnson as VP, Head of Quality finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
PARIS, FRANCE / ACCESSWIRE / January 4, 2023 / Pharnext SA (FR001400BV89:ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative
PARIS, France, January 4th, 2023, 08:30 am CET - Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases. | January 4, 2023
DJ Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates Pharnext Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates 25-Apr-2022
DJ Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates Pharnext Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates 25-Apr-2022